ADHD Treatment Adhansia XR Now Available
Adlon Therapeutics announced the launch of Adhansia XR (methylphenidate HCl extended-release capsules) for the treatment of attention deficit hyperactivity disorder (ADHD) in patients aged 6 years and older.
Other Articles in this Edition
Antipsychotic use in youths with ADHD is low, but still cause for concern
Adult Bipolar Disorder With or Without Childhood ADHD Difficult to Distinguish Using Cognitive Tests
ADHD supplements: Are they effective?
How Parents Can Get Kids with ADHD Prepared to Start School
Carolyn Hax: Does husband’s job-hopping point to ADHD?
ADHD Treatment Adhansia XR Now Available
What are the differences between Strattera and Vyvanse?
Psychiatrist shortage is a national crisis as need for mental health care grows